Related Experiment Video
Updated: Aug 6, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Beta-thalassemia: the Lebanese experience
A Inati1, N Zeineh, H Isma'eel
1Chronic Care Center, Baabda, Lebanon.
Clinical and Laboratory Haematology
|August 11, 2006
Summary
Beta-thalassemia, a prevalent hereditary anemia in Lebanon, requires lifelong management. Prevention strategies like premarital screening are showing success, reducing new diagnoses.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Beta-thalassemia is a significant hereditary anemia in Lebanon.
- The Chronic Care Center (CCC) in Beirut has managed beta-thalassemia patients since 1994.
Purpose of the Study:
- To review the clinical experience with beta-thalassemia at the CCC.
- To analyze patient demographics, treatment outcomes, and complications.
- To discuss preventive measures for beta-thalassemia.
Main Methods:
- Retrospective review of 425 patients (2-68 years old) at the CCC.
- Analysis of patient data including disease type (thalassemia major vs. intermedia), treatment protocols (transfusions, iron chelation), and mortality.
- Review of complication incidence and discussion of prevention strategies.
Main Results:
- 64% of patients have thalassemia major (TM), 36% have thalassemia intermedia (TI).
- Standard treatment includes regular transfusions and desferrioxamine chelation.
- Heart failure caused most deaths among 12 TM patients deceased since 1994.
Conclusions:
- Beta-thalassemia management at the CCC involves transfusions and chelation, with significant complications.
- Preventive measures, including educational campaigns and premarital screening, are crucial.
- Early prevention efforts are demonstrating a reduction in new beta-thalassemia diagnoses.
Related Concept Videos
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.